# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-048067
Filing Date
2024-11-27
Accepted
2024-11-27 17:26:09
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 19488
2 |  | ex1.htm | EX-1 | 3399
3 |  | ex1_001.jpg | GRAPHIC | 591406
4 |  | ex1_002.jpg | GRAPHIC | 528480
5 |  | ex1_003.jpg | GRAPHIC | 560883
6 |  | ex1_004.jpg | GRAPHIC | 528076
| Complete submission text file | 0001493152-24-048067.txt |  | 3066469

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 241512537
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)